SLC2A2 and hepatocellular carcinoma: Glucose transporters SLC2A1 and SLC2A2 are implicated in HCC; SLC2A1 is elevated, while SLC2A2 is decreased, correlating with clinical characteristics and prognosis [82,83,127].